Stay updated with breaking news from Emergent Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions' request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as an over-the-counter emergency treatment for known or suspected opioid overdose, the company said Tuesday.
(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions' request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as
Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff
Worries about the monkeypox outbreak have driven Emergent's shares higher.
The government will expand access to and increase supply of two different formulations to contain the infection